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1. Introduction 
Respiratory syncytial virus is associated with a large spectrum of illnesses ranging from 
mild upper respiratory tract (URT) disease to severe lower respiratory tract (LRT) disease. 
All infections start initially in the upper respiratory tract (URTI), where the virus replicates 
primarily in the nasopharynx (Brandenburg, 2000; Collins and Graham, 2008). The 
incubation period is thought to be 4 to 5 days before the onset of symptoms, which are 
characterised by a runny nose/nasal congestion, a non-productive cough, ear pain, sinus 
pain and sometimes a low-grade fever (Brandenburg, 2000; Freymuth et al, 2001; Rietveld, 
2003). In most cases the infection induces mild illnesses of the upper airways, such as 
rhinitis, pharyngitis or otitis media. However, in some cases (mainly children < 2 years of 
age) the infection progresses within 1 to 3 days to the lower respiratory tract (LRTI) 
(Brandenburg, 2000; Graham et al, 2002; Tregoning and Schwarze, 2010) and may lead to 
mild or severe LRT diseases (tracheobronchitis or croup, bronchitis, bronchiolitis or 
pneumonia). The mechanisms by which RSV spreads to the LRT remain unknown but 
aspiration of nasopharyngeal secretions loaded with progeny virus is a plausible 
explanation (Brandenburg, 2000; Freymuth et al, 2001; Rietveld, 2003).  
In two surveillance studies collating clinical data on RSV over a 20-year period, RSV-LRTI 
was identified in 37.8% children (2 weeks to 5 years-old, Fischer et al, 1997) and 26% healthy 
adults (18 to 60 years, Hall et al, 2001) were diagnosed with a RSV symptomatic infection. 
Moreover, Fischer et al (1997) observed that between 0 and 12 months of age almost half of 
the children diagnosed with RSV infection developed LRT disease, with a peak at 60% for 
infants aged between 3 to 6 months. For yet unknown reasons, several factors pre-dispose to 
severe forms of RSV-LRTI, including young age (< 3 weeks to 3 months), old age (> 65 
years), premature birth (<34 weeks of gestation) and underlying medical conditions 
(bronchopulmonary dysplasia, congenital heart disease and congenital or acquired 
immunodeficiencies) (Brandenburg, 2000; Collins and Graham, 2008).  
There are currently three types of severe disease associated with a RSV-LRTI: bronchitis, 
which is a disease limited to the large airways (bronchus), bronchiolitis, which involves the 
small conducting airways (bronchioles), and pneumonia, which implicates the involvement 
of the alveolar compartment (Tregoning and Schwarze, 2010). These illnesses are often 
characterised by dyspnea (breathing discomfort/difficulties), tachypnea (rapid breathing, 
>20 breaths/min), chest retractions, polypnea (increase of breathing frequency, bronchial 
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obstruction), wheezing (bronchiolar involvement) and rales/ronchi (crepitations, alveolar 
involvement) (Freymuth et al, 2001; Rietveld, 2003). Thus, in a 13-year prospective study in 
infants and children in the United states, RSV was detected in 43%, 25%, 11% and 10% of 
paediatric hospitalisations for bronchiolitis, pneumonia, bronchitis and croup, respectively 
(Collins and Graham, 2008). RSV-LRTI can vary from mild to severe, the latter requiring 
admission to the intensive care unit (ICU) since the patients often need respiration support. 
Furthermore, Wang et al (1995) observed that among children hospitalised with RSV-LRTIs, 
0.9% were associated with fatal cases. However, the mechanisms leading to either an URTI 
or a LRTI upon RSV infection are still not well understood and require further investigation. 
In order to facilitate a better understanding of severe RSV-induced diseases, this chapter 
will review the histopathology of RSV fatal cases, the cellular responses to infection and the 
factors associated with the severity of the illness in humans. 
2. Histopathology of fatal RSV cases 
Since its isolation in 1956 several reports have investigated the histopathology associated with 
fatal cases of RSV in children (Aherne et al, 1970; Downham et al, 1975; Ebbert et al, 2005; 
Johnson et al, 2007; Kurlandsky et al, 1988; Neilson et al, 1990; Padman et al, 1985; Welliver et al, 
2007) and adults (Levenson et al, 1987), starting with the autopsies of the two unfortunate 
recipients of the first-ever RSV vaccine candidate. Undertaken in the late sixties, this first 
human RSV vaccine field trial was based on a formalin-inactivated alum-precipitated whole 
virus (FI-RSV). However, instead of inducing protective immunity, FI-RSV primed the vast 
majority of vaccinees for exacerbated disease upon exposure to natural RSV infection, leading 
to the deaths of two of the vaccinated infants. The autopsies of these infants revealed a 
prominent neutrophilic and lymphocytic pulmonary infiltration, with some evidence of 
eosinophilia (Graham et al, 2002; Prince et al, 2001). These observations were further 
perpetuated by similar findings in animal models of RSV infection (cotton rats, BALB/c mice, 
monkeys), which led to the general belief of an immunopathogenic nature of RSV disease.  
In this section we will comprehensively review the histopathological observations in 
children and adults in 3 parts: the damage and cytopathic effects caused to the lungs, the 
site of RSV infection and the type and site of cell infiltrates. 
2.1 Damage and cytopathic effects to the lungs 
Bronchiolitis and pneumonia are most commonly associated with severe forms of RSV-LRTI 
and, not surprisingly, are also the most frequent diseases linked with a fatal outcome. As 
stated above, they involve different areas of the lower respiratory tract and, therefore, their 
histopathological characteristics are distinct. 
2.1.1 Bronchiolitis 
In a study involving 22 children, Aherne et al (1970) described the hallmarks of each disease 
when associated with RSV. The earliest lesion of acute bronchiolitis is the necrosis of the 
bronchiolar epithelium, principally the destruction of ciliated cells, followed by the peri-
bronchiolar infiltration of lymphocytes, macrophages and some plasma cells. Markers of 
apoptosis, such as caspase 3 (Welliver et al, 2007) and Fas (Reed et al, 2008), were clearly 
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evident in bronchiolar epithelium cells of children who died from fatal RSV LRTI compared 
with uninfected paediatric lung tissue. However, alveoli are usually not involved in the 
bronchiolitis inflammatory process. 
The submucosa and adventitial tissues become oedematous and congested but typically there 
is no damage to elastic fibres or muscle. The secretion of mucus is enhanced and a thick plug 
forms in the bronchiolar lumina composed of epithelial cell debris, fibrin and inflammatory 
cells (Fig. 1) (Downham et al, 1975). The occlusion of the bronchioles may lead to various 
degrees of mechanical lesions, the most severe being the complete collapse of the alveoli that 
the affected bronchiole supplies. At later stages, two types of cells can be seen that are thought 
to be involved in the regeneration of the bronchiolar epithelium: undifferentiated pleomorphic 
cells lining small bronchioles, varying in thickness and showing occasional mitotic activity; 
and more occasionally, elongated basophilic cells spreading over recently denuded lamina 
propria. In a comparable study of fatal RSV-LRTI in children (1 to 14 months old) Neilson et al 
(1990) similarly reported the occasional uneven proliferation of epithelial cells with protrusion 
into the bronchiolar lumen, creating a polypoid appearance. 
 
Fig. 1. Histological appearance of lungs of children deceased from a severe RSV 
bronchiolitis. Varying degrees of peribronchiolar lymphocytic infiltration can be observed 
alongside a necrosis of the bronchiolar epithelium. The small bronchioles are often plugged 
with mucus and cell debris. Magnification x 112. Reproduced from [Role of respiratory 
viruses in childhood mortality, Downham et al, 1 (5952), 235-239, 1975] with permission 
from BMJ Publishing Group Ltd. 
2.1.2 Pneumonia 
The most thorough description of fatal pneumonia associated with RSV was published in 
2007 by Johnson et al (2007). In their histopathology report of autopsy tissues from 4 
children, they noted extensive damage to the lungs, from medium and small bronchioles to 
the alveoli. As outlined in an earlier study of fatal pneumonia in infants (Aherne et al, 1970), 
Johnson et al (2007) observed widespread destruction of bronchial and bronchiolar 
epithelium resulting in occlusion of the airways by cell debris (sloughed epithelial cells), 
fibrin, a minor component of mucin and inflammatory cells (mostly macrophages). 
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Conversely, Welliver et al (2007) were unable to stain for mucus in their autopsy slides. In 
addition, the small bronchioles were surrounded by fibrotic tissue (excess connective tissue) 
and the mucosa was often hyperplastic (Kurlandsky et al, 1988). 
Similar to bronchiolitis, occasional marked uneven proliferation and metaplasia of the 
bronchiolar epithelium could be detected. These resulted in papillary protusions, which are 
likely to contribute to airway narrowing. This feature was seen in other comparable studies 
of infant cases (Aherne et al, 1970; Neilson et al, 1990) and also in an elderly woman 
(Levenson et al, 1987). 
One patient in the Johnson et al (2007) study showed multiple syncytia lining the 
bronchiolar epithelium, an observation that had been previously reported in children 
(Neilson et al, 1990). However, if occasional intra-bronchiolar and intra-alveolar syncytia can 
be seen in fatal RSV pneumonitis in children (Welliver et al, 2007), multiple giant nucleated 
cells are not a common occurrence associated with RSV pneumonitis. Giant cell pneumonia 
is the typical disease syndrome of immunosuppressed patients, such as subjects with 
immunodeficiency diseases or recipients of organ transplant (bone-marrow, lung) (Graham 
et al, 2002). Indeed, several patients in the study by Neilson et al (1990) had underlying 
conditions associated with various degrees of immunodeficiency, which may explain their 
observations. However, there were no reported underlying conditions that could justify this 
pattern in the study by Johnson et al (2007). 
As for bronchiolitis, pneumonia is characterised by a massive bronchiolar inflammation and 
a peri-bronchiolar infiltration of inflammatory cells, deep to the muscularis layer. The 
pattern of inflammatory infiltrate around an airway appears to be determined by the 
distribution of arterioles adjacent to the airway. Sometimes, the infiltrates around the 
bronchovascular bundle can be so dense that they resemble hyperplastic node follicles, also 
called bronchiolar-associated lymphoid tissue (BALT), which in turn are responsible for the 
congestion of the arterioles. Occasionally, BALT nodules projected into the bronchiolar 
lumens, thereby participating in the narrowing of the airways (Johnson et al, 2007). 
One of the hallmarks of pneumonitis is the diffuse alveolar damage caused by RSV. This is 
characterised in children and adults by the proliferation of type II pneumocytes, in order to 
regenerate destroyed type I pneumocytes, but also interstitial and intra-alveolar fibrosis 
(Aherne et al, 1970; Kurlansky et al, 1988; Levenson et al, 1987). In addition, an extensive 
interstitial infiltration occurs, leading to a marked capillary congestion, and is often 
accompanied by intra-alveolar leakage of fibrin and inflammatory cells (macrophages and 
occasional neutrophils). Due to a lack of aeration, alveolar parenchyma necrosis and intra-
alveolar haemorrhage can be observed in severe cases of pneumonitis, along with oedema and 
the apparition of a thick hyaline membrane lining the alveoli (Aherne et al, 1970; Johnson et al, 
2007). This latter feature was also observed in elderly patients (Levenson et al, 1987). 
The observations described above are further supported by Downham et al (1975), who 
corroborated the histopathology described for either bronchiolitis or pneumonia. In this 
study, they assessed the histological changes in the lungs of 13 children without knowledge 
of the virus findings. The 2 categories of pathological changes in patients that were later 
diagnosed with a RSV infection were: 1/ varying degrees of peribronchiolar lymphocytic 
infiltration, necrosis of bronchiolar epithelium, plugging of the small bronchioles by mucus 
and cell debris; 2/ lymphocytic infiltration of alveolar walls and interstitial lung tissue, 
www.intechopen.com
 Cellular and Molecular Characteristics of RSV-Induced Disease in Humans 101 
sometimes associated with a minor degree of peribronchiolar lymphocytic infiltration (Fig. 2). 
Indeed, the type 1 and 2 patterns showed striking similarities with the histopathology of fatal 
RSV bronchiolitis and pneumonia cases, respectively. 
 
Fig. 2. Histological appearance of lungs of a child that died following severe RSV 
pneumonia. Cell infiltration of alveolar walls and interstitial lung tissue is clearly 
identifiable and is associated with a peribronchiolar infiltration. Magnification x 84 
Reproduced from [Role of respiratory viruses in childhood mortality, Downham et al, 1 
(5952), 235-239, 1975] with permission from BMJ Publishing Group Ltd. 
2.2 Site of RSV infection in the lungs 
In fatal cases of RSV disease, infection was highly restricted to the superficial cells of the 
respiratory epithelium (Johnson et al, 2007; Neilson et al, 1990; Welliver et al, 2007). In the URT 
RSV initially replicates in the ciliated cells of the nasopharynx, while in the LRT ciliated cells of 
the large and small airways and type I pneumocytes in the alveoli are the major targets 
(Collins and Graham, 2008; Graham et al, 2002). This is consistent with the early loss of 
cilia/ciliated cells observed by Aherne et al (1970) in both bronchiolitis and pneumonitis 
illnesses. This was elegantly demonstrated in 2 recent studies of young children (1 to 15 
month-old) who died of “atypical pneumonia” (Johnson et al, 2007) or of a severe LRTI 
(Welliver et al, 2007) due to RSV. Although Welliver et al (2007) did not mention the type of 
disease, the histopathological aspects pointed towards a severe form of pneumonitis. In these 
publications Johnson et al (2007) and Welliver et al (2007) detected extensive RSV-positive 
staining in the bronchial and bronchiolar epithelium of all cases (Fig 3a and b), but also in the 
alveolar epithelium of most patients (Fig. 3a). As expected, Johnson et al (2007) observed RSV-
positive staining in ciliated cells but also, surprisingly, in non-ciliated cells. As suggested 
previously (Aherne et al, 1970), this may be due to a loss of cilia following RSV infection.  
They also noted that the infection was restricted to the superficial epithelium, as basal cells 
routinely stained negative. Evidence from the infection of well differentiated human airway 
epithelial cells (WD-HAE) by RSV indicates that progeny virus release is polarised, forcing the 
virus to the apical surface (Villenave et al, unpublished observations; Zhang et al, 2002). 
Coupled with this, the tight junctions are likely to restrict access of the released virus to the 
basal layers. Interestingly, when Zhang et al (2002) damaged their WD-HAE cultures so that 
www.intechopen.com
 Human Respiratory Syncytial Virus Infection 102 
some basal cells were exposed, there was still very little RSV infection of these cells, implying 
that they somehow have an innate protection from RSV. In addition, Johnson et al (2007) 
further identified the infected alveolar cells as being predominantly type I pneumocytes but 
also some cuboidal cells thought to be reparative type II pneumocytes. At this level, RSV 
antigens were detected in a continuous linear fashion along the alveolar surfaces. Similarly, 
they found that the smallest airways often had circumferential staining, while the larger 
airways showed a patchy RSV immunostaining, often localised in clusters of 3 to 5 cells.  
Several histopathology reports described RSV antigens in giant multinucleated cells (Johnson 
et al, 2007; Kurlansky et al, 1988; Neilson et al, 1990; Welliver et al, 2007) when these syncytia 
were observable, and also within the material obstructing the lumen of the bronchioli and 
alveoli (Johnson et al, 2007). More specifically, this material was composed of cell debris, 
infiltrating alveolar macrophages (Johnson et al, 2007) and sloughed bronchiolar and alveolar 
cells (Neilson et al, 1990). The positive staining of macrophages for RSV antigens may have 
resulted from phagocytosed antigen or the infection of these cells by RSV. Indeed, there is 
evidence suggesting that RSV can infect and replicate in a human macrophage-like cell line 
(Zhao et al, 2007) and in human monocyte-derived macrophages (Spann et al, 2004). 
Finally, cytoplasmic inclusions have also been observed, both in children (Neilson et al, 1990; 
Aherne et al, 1970) and adults (Levenson et al, 1987), although this is not a systematic feature 
in RSV subjects (Johnson et al, 2007). These inclusions can be granular, basophilic and 
peripherally located (Neilson et al, 19990) or homogenous eosinophilic and paranuclear in 
location (Levenson et al, 1987; Neilson et al, 1990). They can vary markedly in size and are 
occasionally surrounded by halos. These inclusions are found in the cytoplasm of bronchial, 
brionchiolar and alveolar epithelial cells, as well as within syncytia and sloughed intra-
bronchiolar and intra-alveolar cells (Aherne et al, 1970; Levenson et al, 1987; Neilson et al, 
1990). However, it is still unclear what these inclusions are or to what extent they are 
involved in the pathology. 
Interestingly, Welliver et al (2007) compared histopathology findings between RSV and 
influenza fatal cases and showed that viral antigen was more extensively present in RSV 
subjects and that damage to the bronchiolar epithelium was also greater. This might suggest 
an association between viral load and disease severity, as was hypothesised previously 
(DeVincenzo et al, 2005). On the other hand, a closer examination of images from various 
reports shows vast areas of intact virus-infected cells, especially in the bronchiolar 
epithelium, implying that the infection might not be the only phenomenon involved in the 
cytopathic effects (Welliver et al, 2007). The uneven distribution of the damage across the 
lungs, another characteristic associated with RSV fatal cases, further reinforces this 
impression. For instance, Johnson et al (2007) described diffuse pulmonary oedema in areas 
uninvolved with pneumonitis and Bronchiolitis and Aherne et al (1970) found that the 
severity of the pathological changes varies widely from one region to another. It is also 
important to note that while the infection can be patchy, the damage to the bronchiolar 
epithelium and alveoli is often widespread, as is the infiltration of immune cells, such as 
macrophages and neutrophils. This theory of an immune-mediated disease is supported, at 
least partly, by work on ex vivo models of human WD-PBECS. These models showed limited 
gross cytopathic effects following RSV infection (mainly restricted to the ciliated cells) 
(Henderson et al, 1978; Zhang et al, 2002; Villenave et al,– unpublished observations), 
although increased epithelial cell sloughing was observed compared to uninfected controls. 
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However, the extent of sloughing and damage in vivo is unlikely to explain the widespread 
sloughing of epithelial and type I/II penumocytes observed in autopsy cases (Aherne et al, 





Fig. 3. Immunohistochemical staining for respiratory syncytial virus (RSV) antigen in 
bronchiolar and alveolar tissues from infants with lower respiratory tract infection (LRTI). 
(a) Autopsy tissues were obtained from human infants with fatal cases of LRTI caused by 
RSV. Normal infant lung tissue (from an infant that died of asphyxia) is stained as a control. 
Brown stain indicates the presence of viral antigen. Original magnification x 40. (Welliver et 
al, Severe human lower respiratory tract illness caused by respiratory syncytial virus and 
influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte 
responses, The Journal of Infectious Diseases, 2007, 195, 8, 1126-36, by permission of Oxford 
University Press) (b) Medium-sized muscular bronchioles demonstrate RSV antigen 
circumferentially and restricted to the apical epithelium. Dark purple stain indicates RSV 
antigen. Original magnification x 25. Reprinted by permission from Macmillan Publishers 
Ltd: [Modern Pathology] (Johnson et al, The histopathology of fatal untreated human 
respiratory syncytial virus infection, 20 (1), 108–119), copyright (2007). 
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2.3 Inflammation and cell infiltration 
2.3.1 Bronchiolitis versus pneumonia 
One of the common aspects of fatal RSV bronchiolitis and pneunmonia is the massive 
infiltration of multiple inflammatory cell types into the airways. The main cells composing 
the infiltrates included macrophages, lymphocytes, neutrophils and, to a lesser extent, 
eosinophils, or subsets of these populations. However, their proportions among the infiltrate 
and, more importantly, the areas of infiltration differ depending on the form of the disease 
and the strength of the immune system at the time of death. 
The inflammatory cells are centred on the bronchial arteries and arterioles, consistent with 
their migration out of the bloodstream. They are also massively detected in the sub-
muscularis layer of the peri-bronchiolar tissue (Fig. 4), indicating their migration from the 
arteries/arterioles towards the airways (Johnson et al, 2007). Therefore, due to the 
distribution of the pulmonary arteries, which are surrounding large and medium-sized 
bronchiolar branches, the inflammatory infiltrate appears symmetrical and circumferential 
around medium bronchioles and larger airways. On the other hand, because of the 
diminution of blood vessels converging in the smallest airways, such as terminal 
bronchioles, the inflammation is often asymmetrical and densely localised between 
arterioles and the most proximal bronchiole. Overall, the pattern of the inflammatory 
infiltrate around an airway appears to be determined by the distribution of the blood vessels 
(arteries and arterioles) adjacent to the airway (Johnson et al, 2007). 
In the case of pneumonitis, the inflammation is equally important at the alveolar level. In 
numerous reports of fatal pneumonitis, infiltrating cells are extensively seen in the 
alveolar interstitium (interstitial pneumonitis) (Fig. 2) and/or within the intra-alveolar 
exudate (intra-alveolar pneumonia). These observations were consistent in children 
(Aherne et al, 1970; Downham et al, 1975; Johnson et al, 2007; Kurlansky, 1988; Neilson et 
al, 1990; Welliver et al, 2007), adults (Levenson et al, 1987) and immunocompromised hosts 
(Hertz et al, 1989; Padman et al, 1985) 
Irrespective of whether there is a bronchiolar or alveolar inflammation, the main cells 
migrating from the blood stream towards the airways are mononuclear cells, with a 
predominance of macrophages followed by lymphocytes. Their distribution is diffuse 
around the bronchiolar lumen (submuscular area) and within the alveolar parenchyma, and 
they are a component of the airway plug. 
2.3.2 Mononuclear cells 
In fatal cases of RSV, macrophages (CD68+ cells) were detected in great abundance around 
the bronchioles and in the bronchiolar exudate, the alveolar interstitium (interstitial 
pneumonia) and/or within the alveolar lumen (intra-alveolar pneumonia) (Johnson et al, 
2007, Welliver et al, 2007). Thus, despite their submuscular localisation in the case of an 
acute bronchiolitis (Fig. 5a), macrophages are able to migrate through the smooth muscle 
towards the bronchiolar lumen. This ability to migrate is illustrated by Johnson et al (2007) 
who observed inflammatory cells moving through gaps across the muscularis (Fig. 5b) and 
detected the presence of macrophages within the bronchiolar epithelium. On the other hand, 
at the alveolar level, infiltrated macrophages represent either alveolar macrophages that 
migrated inside the alveolar space or macrophages that were recruited from the 
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surrounding arterioles/capillaries. Finally, macrophages were also found to be an important 
component of the follicule-like expanded BALT (Johnson et al, 2007). 
 
Fig. 4. The peribronchiolar lymphoid infiltration in acute bronchiolitis. Note also the 
epithelial irregularity. H.E. x 60. Reproduced from [Pathological changes in virus infections 
of the lower respiratory tract in children, Aherne et al, 23 (1), 7-18, 1970] with permission 
from BMJ Publishing Group Ltd. 
 
Fig. 5. Relative segregation of mononuclear cells and polymorphonuclear leukocytes in 
airway. (a) Peribronchiolar mononuclear inflammatory infiltrate is primarily submuscular, 
and is peripheral to the smooth muscle (arrow). L indicates the airway lumen. (b) While 
neutrophils are commonly found in BAL, the predominant cells in the peribronchiolar 
tissues are mononuclear. Neutrophils can sometimes be found migrating across gaps in the 
muscularis (arrow) towards the airway lumen and interspersed within the epithelium 
(dashed arrow). Original magnification x 250 (a and b). Reprinted by permission from 
Macmillan Publishers Ltd: [Modern Pathology] (Johnson et al, The histopathology of fatal 
untreated human respiratory syncytial virus infection, 20 (1), 108–119), copyright (2007). 
T Lymphocytes (CD3+) are also among the mononuclear cells involved in the inflammation 
process. Their distribution within the lung tissue is similar to macrophages - diffuse, peri-
bronchiolar and in the alveolar interstitium (Welliver et al, 2007; Johnson et al, 2007). 
Lymphocytes have also been found in the basal part of the bronchiolar epithelium (Johnson 
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et al, 2007) suggesting that, like macrophages, they can probably migrate through gaps of the 
muscularis. However, the extent of lymphocytic peri-bronchial and interstitial infiltration 
varies between studies, and there are discrepancies in the literature about their presence 
within the bronchiolar or alveolar lumens (Welliver et al, 2007; Johnson et al, 2007 Padman et 
al, 1985; Aherne et al, 1970). It is not clear whether these discrepancies reflect technical 
variations or actual pathological differences in different individuals, for example due to 
underlying medical conditions, or the extent of disease at the time of death. 
Independent of the extent of lymphocyte infiltration, detailed investigation of lymphocyte 
subsets indicated that CD3+CD8+ T cells were predominant over CD3+CD4+ T cells within 
the lung tissue. Furthermore, Johnson et al (2007) specifically observed that the presence of 
CD8+ T cells was often associated with virus-infected areas, which is consistent with a 
putative role in virus clearance. However, Welliver et al (2007) failed to detect granzyme in 
lung tissue suggesting that these CD8+ T cells might not be fully activated or functional 
(granzyme being an effector molecule secreted by cytotoxic T cells to kill infected cells). 
They also failed to detect NK cells (CD56+), another cell type involved with cytotoxic 
responses to viruses. Interestingly, Johnson et al (2007) observed that many of the CD3+ T 
cells were actually CD4 and CD8 negative (double negative, DN), a population suspected to 
be T-regulatory cells (DN Tregs) or NK T cells, but whose role remains to be elucidated. 
Overall, these findings suggest that T lymphocyte activation and cytotoxic activity may be 
abstent or compromised in the lungs at the time when infants are experiencing their most 
severe symptoms. 
In 1970, Aherne et al observed that plasma cells were a component of the peri-bronchiolar 
and peri-alveolar inflammatory response in fatal cases of bronchiolitis and pneumonitis in 
children. This observation was recently corroborated by Welliver et al (2007) and Johnson 
et al (2007), using infant autopsy tissues. More specifically, large populations of CD20+ B 
cells were detected within the BALT follicules and nodules partially obstructing the 
airways (Johnson et al, 2007) (Fig. 6a), the alveolar interstitium and the perivascular areas, 
compared to a control group (infants that died of hypoxia) (Reed et al, 2009) (Fig 6b). 
Indeed, this was concomitant with strong IgA-, IgG- and, to a lesser extent, IgM-positive 
staining within the cytoplasm of cells localised in the alveolar, bronchiolar and 
perivascular spaces (Fig. 7), identifying these cells as plasmocytes (Reed et al, 2009). IgA 
and IgG staining was particularly strong in the alveolar interstitium and exudate, and in 
the sub-muscularis layer of the peribonchiolar area. IgA also appeared to be strongly 
deposited on bronchiolar epithelium, which correlates with its essential involvement in 
mucosal immunity. Because a vigorous B cell response was observed, while in the same 
study CD4+ T cells were rarely detected, Reed et al suggested (2009) the possibility of a T-
independent B lymphocyte antibody production. This hypothesis was supported by the 
perivascular, bronchiolar and alveolar expression of factors known to be involved in T 
cell-independent B cell activation, Ig production and class-switch recombination. These 
factors were identified as vasoactive intestinal peptide (VIP), B cell-activating factor 
(BAFF) and a proliferation-inducing ligand (APRIL). The up-regulation of the APRIL and 
BAFF receptors on lymphocytes having plasmocyte morphological characteristics, 
compared to an age-matched control group, further supported this concept (BAFF-R, 
transmembrane activator calcium modulator and cyclophylin ligand interactor [TACI] 
and B cells maturation antigen [BCMA]). 
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Fig. 6. B cell distribution within the lungs of children who died of severe LRTI. (a) 
Peribronchial lymphoid aggregates are primarily composed of CD20+ B lymphocytes (in 
brown), presumably part of the BALT. During the response to RSV infection, some areas 
appear to develop the appearance of a hyperplastic lymph node follicle. Original 
magnification x 25. Reprinted by permission from Macmillan Publishers Ltd: [Modern 
Pathology] (Johnson et al, The histopathology of fatal untreated human respiratory syncytial 
virus infection, 20 (1), 108–119), copyright (2007). (b) CD20+ lymphocytes were detected at 
autopsy from infants who died of acute RSV LRI (RSV) or asphyxia (ctrl). Original 
magnification, x40. Representative fields from bronchiolar (left), alveolar (middle), and 
perivascular (right) spaces are shown. CD20+ cells were detected by immunohistochemistry 
analysis in formalin-fixed, paraffin-embedded lung tissue. (Reed et al, Innate immune 
signals modulate antiviral and polyreactive antibody responses during severe respiratory 
syncytial virus infection, The Journal of Infectious Diseases, 2007, 199, 8, 1128-38, by 
permission of Oxford University Press) 
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It is important to keep in mind that most of these conclusions regarding lymphocyte 
subsets associated with RSV LRTI are drawn from only 3 reports and a relatively small 
number of infants (Johnson et al, 2007; Reed et al, 2009; Welliver et al, 2007). Also, several 
of the children included in these studies had underlying conditions that are often 
associated with an immunodeficient status (Down’s syndrome, heart disease) (Tregoning 
and Schwarze, 2010). Therefore, while these publications are of huge relevance for the 
understanding of RSV pathology, the particular background of these children suggests 
that generalising these observations to entire populations may be premature and that 
further studies are warranted.  
 
Fig. 7. Detection of immunoglobulin isotypes in samples from individuals with respiratory 
syncytial virus lower respiratory tract infection (RSV LRTI). IgA (upper panels) and IgG 
(lower panels) were detected by immunohistochemistry analysis in formalin-fixed, paraffin-
embedded lung tissue obtained at autopsy from infants who died of acute RSV LRTI (RSV) 
or asphyxia (ctrl). Representative fields from bronchiolar (left), alveolar (middle) and 
perivascular (right) spaces are shown. (original magnification, x40). (Reed et al, Innate 
immune signals modulate antiviral and polyreactive antibody responses during severe 
respiratory syncytial virus infection, The Journal of Infectious Diseases, 2007, 199, 8, 1128-38, 
by permission of Oxford University Press) 
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Denditric cells (DC) are professional antigen presenting cells and essential for inducing 
adaptive immune response against pathogens. They are found in the peripheral blood or 
patrolling within tissues in contact with the external environment, such as the skin or the 
inner lining of the nose/lungs. However, little is known about the extent of their 
involvement during natural RSV infection and only one publication investigated their 
presence in fatal RSV cases (Johnson et al, 2007). Very few DCs were detected in the lungs 
and were mainly localised within bronchiolar epithelium and the peribronchiolar connective 
tissue. It is possible that their low number is a consequence of their migration from the lungs 
to the lymph nodes after detection and capture of the RSV antigens during the early 
inflammatory process. 
2.3.3 Neutrophils and eosinophils 
According to Johnson et al (2007), neutrophils were also a component of the inflammatory 
infiltrate, albeit to a lesser extent than macrophages or lymphocytes. In contrast to the 
diffuse distribution of mononuclear cells, neutrophils are more densely focalised between 
the pulmonary or bronchiolar arteries and the airway lumen. This suggests that these cells 
are responding to chemotractant molecules secreted by the bronchiolar epithelium only, 
whereas factors attracting mononuclear cells are produced by epithelial cells and cells 
within the lung parenchyma (Johnson et al, 2007). As mentioned above, neutrophils are 
principally found in the connective tissue of the peribronchiolar area (submuscularis), in the 
bronchiolar and alveolar lumens but have not been observed within the alveolar interstitium 
(Johnson et al, 2007; Welliver et al, 2007). They can also be detected crossing through gaps of 
the muscular layer and in the basal part of the bronchiolar epithelium, confirming their 
ability to migrate through tissues towards the airway lumen (Johnson et al, 2007). 
Noticeably, the histopathology observations regarding the intra-luminal infiltration of 
macrophages, lymphocytes, neutrophils and eosinophils concur with the cell composition 
of nasopharyngeal (NPL) and broncho-alveolar lavages (BAL) collected from infants 
hospitalised with severe bronchiolitis. However, the ratios of cell types are significantly 
different, with neutrophils consistently being the largest cell population within nasal and 
pulmonary secretions (70 to 80%), followed by mononuclear cells (Brandenburg et al, 2000; 
Everard et al, 1994; Heidema et al, 2007; O’Donnell et al, 2002; Smith et al, 2001). This is 
further supported by the appearance of neutrophil precursors (myelocytes, 
metamyelocytes and banded neutrophils), normally residing in the bone marrow, in the 
peripheral blood of hospitalised RSV patients at a time when disease severity and viral 
load are declining (Lukens et al, 2010). It is likely that the migration of neutrophil 
progenitors from the bone marrow is a consequence of neutrophil exhaustion (and 
depletion of the banded-neutrophil pool in peripheral blood) due to a massive 
recruitment of these cells into the airways. In contrast, in autopsy cases neutrophils were 
often detected in the minority among the intra-luminal infiltrate compared to 
macrophages and lymphocytes (Aherne et al, 1970; Johnson et al, 2007; Welliver et al, 
2007). The reason for this striking contrast is unclear and warrants further investigation. 
Eosinophils can be detected as part of the peribronchiolar cell infiltrate but they are not a 
dominant component of the inflammatory process (Aherne et al, 1970; Johnson et al, 2007). 
For many years these cells were thought to be major players of the inflammatory response 
against RSV since a significant eosinophilia was one of the hallmarks described of the fatal 
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enhanced disease associated with FI RSV vaccination (Graham et al, 2002). However, re-
analysis of the FI-RSV autopsies challenged this dogma, as eosinophils were found to be a 
minor population among the pulmonary infiltrates with an uneven distribution across lung 
tissues, while neutrophilia was the principal characteristic of the inflammation (Graham et 
al, 2002; Prince et al, 2001). Therefore, it remains to be elucidated whether FI-RSV enhanced 
disease is representative of a natural primary RSV infection and to what extent eosinophils 
(and neutrophils) are involved in RSV pathology. 
It is noteworthy that the histopathology of the FI-RSV autopsy cases displayed both 
similarities and discrepancies compared to recent histopathology studies of fatal RSV cases 
(Johnson et al, 2007; Welliver et al, 2007). For instance, in the former cases, Prince et al (2001) 
observed a peribronchiolar inflammation composed of 10% neutrophils, 10% macrophages 
and 80% lymphocytes, while the bronchial exudate contained 50% neutrophils, 30% 
macrophages and 20% lymphocytes. Eosinophils represented 1-2% of the inflammatory cells 
of the sections (Prince et al, 2001), whereas Graham et al (2002) observed many eosinophils. 
Also, according to the original publication describing the autopsies of the FI-RSV recipients, 
the alveoli contained scattered infiltrates of neutrophils and macrophages, or of neutrophils 
and mononuclear cells, depending on the pulmonary lobe examined (Chin et al, 1969). While 
the infiltration of macrophages and lymphocytes in the peribronchiolar and alveolar areas 
are consistent between reports, discrepancies regarding the amount of infiltrating 
eosinophils and neutrophils remain. However, comparable disease enhancement does not 
occur with community-acquired natural RSV infections and re-infections, and, therefore, the 
relevance of FI-RSV-associated pathogenesis to natural infection is unclear (Collins and 
Graham, 2008). It is interesting to note that the histopathological hallmarks of fatal RSV 
bronchiolitis or pneunmonia from normal infants were also identifiable in fatal RSV cases of 
immunocompromised children and adults (Ebbert et al, 2002; Hertz et al, 1989; Padman et al, 
1985). However, the mortality and morbidity is a lot higher in the latter groups, reaching 
50% of infected patients (Graham et al, 2002). 
3. Factors associated with severe RSV infection 
RSV epidemics usually occur over the winter months in temperate climates and in the rainy 
season in hotter climates. In the Northern hemisphere peak epidemic months are commonly 
November to January (Brandenburg, 2000; Garcia et al, 2010; Houben et al, 2011). 
Approximately 70% of children encounter their first infection before the age of one, while 
almost all children are infected at least once before the age of 2 years (Brandenburg, 2000; 
Rietweld, 2003;) and over 50% will have been infected twice (Brandenburg, 2000). About 
40% of young children infected for the 1st time show signs of lower respiratory tract 
involvement, with some developing severe complications necessitating hospital admission 
(Brandenburg, 2000). Overall, 0.5 - 2.5% of infants are hospitalised with RSV infection 
during their first year of life, and 7 - 21% of these children require ventilation support due to 
respiratory failure (Brandenburg, 2000; Rietweld, 2003). RSV is the most common cause of 
bronchiolitis hospitalisation, with one study showing that RSV accounted for 60 - 70% of all 
hospitalisations with bronchiolitis (Garcia et al, 2010). 
Deciphering the factors associated with severe RSV disease is complicated by the fact that 
many published studies define disease severity, and patient inclusion criteria in severe 
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cohorts, differently. Factors such as requirement for mechanical ventilation, admission to 
paediatric ICU, days in hospital and oxygen saturation levels are commonly used, either 
alone or together. There are clearly defined groups of infants that are at high risk of severe 
RSV. These include infants with congenital heart disease, bronchopulmonary dysplasia, 
congenital or acquired immunodeficiencies or prematurity (<32 weeks gestation). However, 
the majority of infants hospitalised with RSV have no known high risk factors. The 
mechanisms leading to severe LRT disease, and possibly death, are still poorly understood. 
It is likely that a multitude of factors influence the course of disease during an infection. We 
postulate that the interrelation of various elements associated with the virus, the host and 
the environment will shape the outcome of RSV disease. 
3.1 Viral factors 
3.1.1 RSV subgroup 
RSV has a single serotype with two major antigenic subgroups (A and B). Both subgroups 
have a worldwide geographical distribution and circulate independently, while their 
seasonal distribution is similar each year (Brandenburg, 2000; Collins and Graham, 2008; 
Rietweld, 2003). In several epidemiology studies, 3 patterns of subgroup A and B 
circulations within communities could be observed: a strong predominance of RSV A 
strains, relatively equal proportions of RSV A and B strains and, occasionally, a strong 
predominance of RSV B strains (Hall et al, 1990; Imaz et al, 2000; Mufson et al, 1988; Taylor 
et al, 1989). Numerous studies have investigated the relationship between disease severity 
and RSV subgroups but the data are inconclusive. In some studies infections with RSV A 
strains were associated with increased severity in children (Hall, et al, 1990; Imaz et al, 
2000; Mufson et al, 1988; Taylor et al, 1989; Walsh et al, 1997), while others failed to detect 
any significant correlation with the subgroup (DeVincenzo et al, 2004; Fodha et al, 2007; 
Martinello et al, 2002). It is possible that the simultaneous circulation of multiple strains of 
each subgroup during an epidemic, the year-to-year variation in virus population, the 
alternated subgroup predominance and the geographical location of the study may 
explain discrepancies between reports (Collins and Graham, 2008; Fletcher et al, 1997; Hall 
et al, 1990; Martinello et al, 2002). Interestingly, in several studies of hospitalised children 
RSV A subgroup infections led to higher mean viral loads compared to RSV B 
(Devincenzo et al, 2004; Fodha et al, 2007; Perkins et al, 2005). However, in view of the 
discrepancies, the biological significance of strain variation in relation to disease severity 
remains unclear. 
3.1.2 RSV strain/genetic variation 
The antigenic homology between RSV subgroups is approximately 25%. The fusion protein 
(RSV F) is the most conserved with 90% amino acid sequence identity and 50% antigenic 
homology between RSV A and B subgroups. The G protein (RSV G) is the most divergent, 
showing only 53% amino acid relatedness and 1 to 7% antigenic homology (Brandenburg, 
2000; Collins et Graham, 2008; Rietweld, 2003). Thus, phylogenetic studies have targeted the 
G gene to differentiate between RSV strains. For instance, Martinello et al (2002) investigated 
the association between RSV G genotypes and disease severity in children during two RSV 
seasons. They found that clade RSV A GA3 isolates correlated significantly with increased 
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clinical severity scores compared to other subgroup A clades (GA2, GA4) and B isolates. 
Previous reports also addressed this issue, although with a different classification of RSV 
strains. Specifically, Hall et al (1990) grouped RSV A and B strains on the basis of their 
reaction with various monoclonal antibodies to RSV G protein. Their data suggested an 
association between one RSV strain (A2) and higher rates of intensive care admission. 
Furthermore, two studies used restriction length polymorphism (RFLP), either of N and F 
genes (Savon et al, 2006) or N and G genes (Fletcher et al, 1997), to define RSV strains. Both 
studies concluded that RSV genotypes F1N4 (RSV F and N clades) and G were associated 
either with longer hospital stay (Savon et al, 2006) or various degrees of disease severity, 
according to their severity criteria (Fletcher et al, 1997). However, in our view these 
observations warrant further investigation. Overall, from our current understanding it is 
reasonable to assume that among the multiple strains simultaneously circulating during an 
RSV season some could be associated with increased severity.  
3.1.3 Viral load 
It is evident from the few published studies available that the importance of viral load in 
relation to RSV disease severity remains controversial. Studies addressing this issue 
determined viral loads in nasal aspirates from naturally infected infants following 
hospitalisation or within the community (Buckingham et al, 2000; DeVincenzo, 2004; 
DeVincenzo et al, 2005; Fodha et al, 2007; Houben et al, 2010; Wright et al, 2002). With the 
exception of the study by Wright et al (2002), there is a growing consensus that mean viral 
titres correlate significantly with disease severity. That RSV disease might be driven mainly 
by the viral load is a seductive idea and would correlate with other virus-associated 
illnesses, such as HIV, cytomegalovirus and influenza virus (DeVincenzo, 2005). 
However, analyses of mean viral titres mask the fact that some individuals in non-severe 
cohorts may have considerably higher virus titres in their nasal aspirates than some 
individuals in the severe cohorts. This is clearly exemplified by Buchkingham et al (2000), 
who presented the virus load data from individuals in the severe and non-severe disease 
cohorts. Their data demonstrated that some individuals in the non-severe cohort had 
virus loads ≥2 log10 pfu/ml higher than some severe cohort counterparts. Such data argue 
strongly against virus load as a predictor of disease severity. On the other hand, in 
contrast to the severe cohort, some individuals in the non-severe cohort had virus loads 
≤2 log10 pfu/ml, which undoubtedly skewed mean data towards reduced values. The 
cumulative data suggest the possibility that a certain minimum virus replication is 
required to cause severe illness, but the degree of replication itself may not be the 
defining characteristic. Interestingly, King et al (1993) reported that in infants co-infected 
with human immunodeficiency virus type 1, prolonged clinical shedding of RSV occurred 
without substantial disease compared to healthy controls, thereby implying a substantial 
role of the host immune system in RSV pathology rather than viral cytopathic effects. In 
our opinion, re-analyses of the published data, in which individual virus titre data are 
stratified into the severe and non-severe cohorts, will greatly help our understanding of 
this important issue. 
Convincing evidence of a correlation between virus load and disease severity was provided 
recently in an elegant RSV challenge study in healthy adult volunteers (DeVincenzo et al, 
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2010). While symptoms were mild and restricted to the URT, virus growth and disease 
severity kinetics paralleled one another, suggesting that the efficiency of virus replication 
was driving symptom severity. A similar temporal association of virus shedding and 
respiratory symptom scores and mucus weight in RSV-challenged healthy adults was 
described by Lee et al. (2004). Moreover, the secretion of specific pro-inflammatory 
chemokines paralleled the viral load and the severity of the disease, hence acting as 
potentially interesting biomarkers (IL-6, IL-8/CXCL8, RANTES/CCL5, TNF-ǂ, MIP-
1ǂ/CCL3). This is consistent with Noah & Becker (2000), who reported that IL-8/CXCL8, 
RANTES/CCL5, MIP-1ǂ/CCL3 and MCP-1/CCL2 concentrations increased in nasal 
lavages recovered during virus shedding from infected adult volunteers. Surprisingly, 
infectivity, virus growth kinetics and disease severity appeared to be independent of the 
initial virus inoculum titres (103 to 105.38 pfu) under the experimental conditions described 
(DeVincenzo et al, 2010). This contrasted with the work by Hall et al (1981), in which 
infectivity and the onset of virus shedding was greatly influenced by the initial inoculum 
(105.2 >> 103.2 TCID50) of the adult volunteers. It is possible, however, that these 
discrepancies might be explained, in part at least, by the use of different RSV strains 
and/or the fact that volunteers were pre-screened for relatively low virus neutralising 
antibody titres before inclusion in the study by DeVincenzo et al (2010). The latter 
hypothesis is consistent with Lee et al (2004), who found a significant correlation between 
pre-inoculation RSV neutralisation antibody titres and infection rates, irrespective of the 
infecting doses tested. 
As the RSV challenge studies cited above were undertaken in healthy adults, who were 
undoubtedly repeatedly exposed to RSV infections prior to inclusion, great care must be 
taken in extrapolating these data and conclusions to infants undergoing primary infection. 
First, in contrast to the adult challenge experiments, in which symptoms were invariably 
restricted to the URT, a large proportion of infants undergoing their first RSV infection have 
symptomatic LRT involvement. Second, such infants are, by definition, immunologically 
naive relative to RSV and do not possess the plethora of anti-RSV memory T and B 
cell/antibody responses evident in adults. Third, young infants in particular, in whom the 
peak of severe RSV disease occurs, are thought to be immunologically immature and are 
therefore likely to respond quite differently to infection compared with adults. 
3.2 Host factors  
3.2.1 High-risk profiles in infants 
As indicated above, underlying heart and lung conditions are factors predisposing to 
severe RSV disease. Patients with diseases such as congenital heart disease (CHD) or 
bronchopulmonary dysplasia (BPD) are often associated with RSV infections of greater 
severity. These conditions are associated with more frequent admission to ICU, prolonged 
hospitalisation, increased requirement and duration for supplemental oxygen, the need 
for mechanical ventilation, increased severity scores and death (Brandenburg, 2000; 
DeVincenzo et al, 2005; Garcia et al, 2011; Kaneko et al, 2001; Rietweld, 2003; Thorburn K, 
2009; Wang et al, 1995; Wright et al, 2002). The precise reasons for aggravated illness in 
these infants are unclear but pre-existing lung diseases will significantly reduce an 
infant’s functional pulmonary reserve capacity, rendering RSV more likely to overwhelm 
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quickly and easily the infant’s defences. Prematurity (Brandenburg, 2000; Fodha et al, 
2007; Garcia et al, 2011; Rietweld, 2003; Wang et al, 1995) and acquired or congenital 
immunodeficiency status (Brandenburg, 2000; Ebbert et al, 2002; Hertz et al, 1989; Padman 
et al, 1985; Rietweld, 2003) are also important predisposing factors for severity. 
It is thought that the reduced transplacental acquisition of maternal antibodies in pre-term 
compared to full-term infants may partially explain the aggravated disease associated with 
RSV infection of premature infants (DeVincenzo et al, 2005). Indeed, in a longitudinal study, 
it was shown that infants with higher maternal neutralizing antibodies had a lower risk of 
RSV hospitalisation and that once infected they developed significantly reduced severity of 
disease (Glezen et al, 1981). Importantly, although prematurity, congenital heart and lung 
conditions (Wang et al 1995; Rietweld, 2003), and immunodeficiencies (Graham et al, 2002; 
Hall et al, 1986; Wang et al 1995) have been associated with higher mortality rates in infants, 
the majority of children admitted to hospital with a RSV infection do not have these high 
risk factors (Brandenburg, 2000; Wang et al, 1995). 
3.2.2 Cytokine and chemokine responses 
A considerable body of information supports the idea that RSV pathogenesis is, at least in 
part, immune mediated. In essence, an over-exuberant immune response to infection is 
thought to cause considerable “collateral” damage in the lungs. The drivers for much of 
these immune responses to infection are cytokines and chemokines. These are small secreted 
proteins that are induced following interaction of pathogen-associated molecular patterns 
with pathogen recognition receptors, such as Toll-like receptors, on host cells. They include 
an expanding family of proteins, whose interaction with specific cellular receptors 
stimulates a range of signal transduction cascades resulting in a plethora of immunological 
functions. Functions of cytokines and chemokines include chemoattraction and activation of 
immune cells, such as neutrophils, lymphocytes, monocytes/macrophages and dendritic 
cells, i.e., hallmarks of RSV pathogenesis. Therefore, an over-exuberant cytokine/chemokine 
response is likely to be associated with RSV immunopathogenesis. 
In this regard, regulated upon activation, normal T cell expressed and secreted 
(RANTES/CCL5), macrophage inflammatory protein 1ǂ (MIP-1ǂ/CCL3), monocytes 
chemotactic protein 1 (MCP-1/CCL2), IL-1ǃ, IL-6, IL-8/CXCL8, IL-10, IL-18, tumours 
necrosis factor ǂ (TNFǂ) and interferon Ǆ-induced protein 10 (IP-10/CXCL10) are among a 
range of cytokines/chemokines demonstrating increased expression in nasal aspirates, BALs 
or blood from RSV infected infants (Barmejo-Martin et al, 2007; Garofalo et al, 2001; 
McNamara et al, 2004; McNamara et al, 2005; Murai et al, 2007; Noah et al, 2002; Roe et al, 
2011; Van Benten et al, 2003). Furthermore, the levels of some of these molecules correlated 
with disease severity. For example, Garofalo et al (2001) reported that MIP-1ǂ/CCL3 was 
markedly increased in nasopharyngeal secretions from infants with severe RSV bronchiolitis 
compared to those with RSV-URTI only or mild bronchiolitis. Similarly, Van Benten et al 
(2003) found that increased numbers of IL-18 positive cells in nasal brushes from RSV-
infected infants was specific for bronchiolitis, as similar increases were not detected in 
infants with only RSV-URTI. 
Despite the strong evidence of correlations between cytokine and chemokine expression 
levels and RSV infections, it is still unclear whether these relationships are temporal or 
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causal in relation to RSV-induced disease and disease severity. The functions of some of 
these molecules are consistent with a causal role, but formal proof in humans will be very 
difficult to achieve. In support of a causal role, an elegant study by Juntti et al (2009) 
indicated that IL-6 and IL-8 responses following LPS stimulation of cord blood samples 
were predictive of disease severity following later infection. In essence, cord blood from 
infants subsequently hospitalised with RSV had higher combined IL-6 and IL-8 responses 
to LPS stimulation than cord blood from RSV-infected infants treated as outpatients. 
However, another limitation of these studies is the fact that only RSV infection was 
confirmed in the infants – co-infections with other respiratory pathogens were not 
considered. Therefore, the possibility remains that some of the data on 
cytokine/chemokine expression level correlations with RSV disease severity might be 
compromised by co-infections at the time of sampling. 
3.2.3 Genetic polymorphisms 
As outlined above, the majority of infants hospitalised with RSV have no underlying high-
risk profiles. Furthermore, only a small proportion of infants from any given birth cohort 
end up with severe RSV disease. This suggests the possibility that genetic polymorphisms 
may be implicated in predisposing infants to severe disease. A number of groups have 
attempted to address this question using genetic association studies. Not surprisingly, in 
view of their correlations with severe RSV disease, much of the initial work focussed on 
specific cytokine/chemokine genes and their receptors. A comprehensive list of these 
haplotypes and polymorphisms associated with severe RSV disease was recently provided 
by Miyairi and DeVincenzo (2008), T Tregoning and Schwarze (2010) and Zeng et al (2011). 
They include such cytokine genes as IL-4, IL-8, IL-10, IL-13 and IL-18, and receptor genes 
like CCR5, CD14, CX3CR1, IL4RA and TLR4. Confirmation of these associations may 
provide the basis for identifying, from birth, otherwise healthy infants who are at risk of 
severe RSV disease. It would also provide the rationale for including such infants in the high 
risk groups that currently benefit from the immunoprophylaxis provided by palivizumab, 
an anti-RSV F monoclonal antibody administered to high risk infants before and during the 
RSV season. However, much work remains to be done to validate these genetic associations. 
3.3 Environmental factors 
The environment also plays a role on the extent of RSV infection as some of these factors can 
impact on the exposure to the virus or lung functions. Thus, day care attendance or crowded 
living conditions (siblings) are recognised risk factors for RSV hospitalisation, lower 
respiratory tract involvement (Rietweld, 2003) and admission to ICU (DeVincenzo et al, 
2005). This association with disease severity is likely a consequence of the high infectivity of 
the virus. A recent survey of RSV infection in the community attempted to define several 
significant predictors of RSV LRTI (Houben et al, 2010). As expected, they included day care 
and siblings but other factors such as a high parental education level, a date of birth outside 
RSV season (April to September) and, surprisingly, a birth weight >4 kg. However, no 
association was identified with maternal smoking. Thus, this study concluded that the risk 
of RSV-LRTI was 10 times higher for children who attended day care, had older siblings, 
had high parental education level, a birth weight >4 kg and were born between April and 
September. A comprehensive review of the literature on RSV disease risk factors by Simoes 
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(2003) drew similar conclusions regarding day care attendance and crowding/siblings as 
important environmental factors for severe RSV-LRTI. However, in contrast to Houben et al 
(2010), birth during the first half of the RSV season (September to November) was found to 
be a risk factor. 
4. Conclusions 
In this chapter we have attempted to provide a comprehensive overview of the 
consequences of RSV infection in humans, with particular emphasis on severe disease 
characteristics in otherwise healthy infants. There is a general consensus that RSV disease is 
a mulitfactorial phenomenon implicating virus, host and environmental elements. However, 
the mechanisms by which RSV causes disease in humans remain largely unknown. Ethical 
and clinical constraints provide challenging obstacles to elucidating these mechanisms 
directly in human subjects. Animal models of RSV disease have undoubted roles to play in 
addressing specific concepts relating to RSV pathogenesis, e.g., gene knockout studies, 
which cannot be undertaken in humans. However, as they are generally only capable of 
modelling some aspects of RSV pathogenesis in humans, extrapolating data derived from 
animal models to human RSV disease has been less than spectacular to date. In our opinion, 
ultimate success in deciphering the molecular mechanisms of RSV disease in humans is 
likely to come from studies directly in humans and/or in authentic ex-vivo/in-vitro human 
tissue models. A comprehensive understanding of RSV pathogenesis in humans is the first 
step in addressing these issues and, ultimately, to finding prophylactic and/or therapeutic 
solutions for this devastating viral pathogen. 
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